A coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. In terms of in silico activities—basically, those using ...
The COVID-19 pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has crippled global healthcare systems and triggered an economic crisis in many countries. The ...
Despite its relevance in our everyday lives, toxicology is a relatively new field of science. As such, most traditional toxicity tests were highly dependent upon in vivo models for evaluating the ...
Researchers have completed the first genome-scale model of the microbe that causes tuberculosis. The model may be a highly useful tool to identify new drug targets and design new vaccines.
AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...
Available to watch now, this webinar sponsored by the IOP Publishing journal, Progress in Biomedical Engineering, explores the advances in in silico trials of medical products This webinar has been ...
SHORTLY after gaining a neuroscience degree, young film-maker Noah Hutton fell into the orbit of Henry Markram, a neuroscientist based at the Swiss Federal Institute of Technology in Lausanne. Markram ...
ATRIMED’s work is driven by a women-led leadership and research culture that emphasizes interdisciplinary collaboration and long-term scientific investment. From data curation to algorithm development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results